drugset / Trial / NCT03822520
Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib
RandomizedCrossoverOpen-labelOther
Summary
This study is conducted to evaluate effect on QT/QTc Interval after multiple dose of celecoxib among healthy adult volunteers. It is randomized, open-label, negative and postive control, and crossover study. Volunteers will be mainly checked up through ECG to find out changes of QT/QTc interval during the study.
Timeline
- Start
- 2017-06-30
- Primary completion
- 2018-05-25
- Completion
- 2018-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | Oral |
| Subject | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.